Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Spondyloarthritis Management

Initial Treatment Approach

  • The American College of Physicians recommends first-line pharmacological treatment with NSAIDs at the lowest effective dose for patients with axial spondyloarthritis, with continued evaluation and monitoring 1, 3
  • The American College of Rheumatology suggests using NSAIDs at maximum tolerated doses, weighing risks and benefits for patients with axial spondyloarthritis 4, 5
  • If the first NSAID is not effective after 2-4 weeks, another NSAID can be tried for patients with axial spondyloarthritis 1, 3
  • All patients with axial spondyloarthritis should be referred to a specialist for a structured exercise program, as home exercises are efficacious and should be recommended to all patients 1, 2
  • Physical therapy may be more beneficial than home exercises for some patients with axial spondyloarthritis 4, 5
  • Hydrotherapy can be considered for pain management in patients with axial spondyloarthritis 1, 3
  • For peripheral spondyloarthritis, corticosteroid injections are first-line for nonprogressive monoarthritis, and standard disease-modifying anti-rheumatic drugs (DMARDs) are indicated for peripheral polyarthritis, oligoarthritis, and persistent monoarthritis 1, 6
  • NSAIDs can be added to DMARDs at the lowest effective dose for patients with peripheral spondyloarthritis 1, 3

Referral to a Rheumatologist

  • Referral to a rheumatologist is indicated for patients with suspected axial spondyloarthritis who have back pain starting before age 45 that has lasted more than 3 months, plus at least 4 of the following criteria: back pain occurring before age 35, waking at night due to symptoms, buttock pain, improvement in pain with movement or within 2 days of taking an NSAID, first-degree relative with spondyloarthritis, or current or previous arthritis, enthesitis, or psoriasis 1, 7
  • Patients with persistently high disease activity despite conventional treatments should be referred to a rheumatologist 4, 5
  • Patients with difficulties in daily activities despite NSAID treatment should be referred to a rheumatologist 1, 2
  • Immediate referral to an ophthalmologist is recommended for symptoms of uveitis (eye pain or redness) 1, 3

Treatment Targets and Monitoring

  • Treatment should be guided by a predefined treatment target agreed upon between patient and rheumatologist, with clinical remission/inactive disease as the major treatment target 4, 5, 8
  • Disease activity should be monitored using clinical signs, symptoms, and acute phase reactants, and treatment should be adjusted if the target is not reached 4, 5, 8
  • Continuous NSAID use is preferred for patients who respond well and remain symptomatic 4, 5

Important Considerations

  • Early diagnosis and treatment are crucial, as there is typically a 5-7 year delay between first symptoms and diagnosis, and 75% of patients with axial spondyloarthritis show good response to NSAIDs within 48 hours 9, 7
  • Do not rule out spondyloarthritis based solely on a negative HLA-B27 test or normal inflammatory markers 6, 3
  • Analgesics like paracetamol and opioids should only be considered for residual pain after recommended treatments have failed 2, 4